Cargando…
Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells
Glioblastoma (GBM) is both the most common and the most lethal primary brain tumor. It is thought that GBM stem cells (GSCs) are critically important in resistance to therapy. Therefore, there is a strong rationale to target these cells in order to develop new molecular therapies. To identify molecu...
Autores principales: | Stangeland, Biljana, Mughal, Awais A., Grieg, Zanina, Sandberg, Cecilie Jonsgar, Joel, Mrinal, Nygård, Ståle, Meling, Torstein, Murrell, Wayne, Vik Mo, Einar O., Langmoen, Iver A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694895/ https://www.ncbi.nlm.nih.gov/pubmed/26295306 |
Ejemplares similares
-
Phenotypic and Expressional Heterogeneity in the Invasive Glioma Cells()()
por: Fayzullin, Artem, et al.
Publicado: (2018) -
Targeting PBK/TOPK decreases growth and survival of glioma initiating cells in vitro and attenuates tumor growth in vivo
por: Joel, Mrinal, et al.
Publicado: (2015) -
Knockdown of NAT12/NAA30 reduces tumorigenic features of glioblastoma-initiating cells
por: Mughal, Awais A., et al.
Publicado: (2015) -
Expansion of Multipotent Stem Cells from the Adult Human Brain
por: Murrell, Wayne, et al.
Publicado: (2013) -
The efficacy of a coordinated pharmacological blockade in glioblastoma stem cells with nine repurposed drugs using the CUSP9 strategy
por: Skaga, Erlend, et al.
Publicado: (2019)